Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisinopril for kidney damage in patients with Fontan circulation
ACTRN12618001124224Phase 3Not yet recruiting
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nephropathy comparing Lisinopril with Placebo (2 arms). Primary endpoint: Change in proteinuria measured by urine albumin-creatinine ratio. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
lisinopril
03
Conditions
nephropathy
Beyond the preview
Go deeper on ACTRN12618001124224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001124224.